Research at the UKE?
DE
Welcome to the
Hamburg Center for Translational Immunology (HCTI)
Through translational research, our goal is to bridge the gap between laboratory discoveries and clinical applications, propelling the advancement of pioneering diagnostic tools, therapeutic interventions, and treatment modalities within the realm of medical science.
Vision
We envision a future where an interdisciplinary approach, bridging the gap between laboratory research and clinical care holds the key to unlocking innovative solutions and improving patient outcomes
Laboratories & Projects
Explore our captivating laboratories and cutting-edge research projects, where our teams address scientific questions with enthusiasm and drive forward translational research.
HCTI Background
Background information and goals of the HCTI
News & Events
Find news & current events here.
HCTI Board Member
Prof. Dr. Petra Arck
HCTI Board Member
Prof. Dr. Petra Arck is a distinguished Professor of Experimental Feto-Maternal Medicine at the University Medical Center Hamburg-Eppendorf (UKE), where she leads the Laboratory for Experimental Feto-Maternal Medicine. Her research focuses on understanding the maternal immune system during pregnancy to enhance the health of both mother and child.
Dr. Arck completed her medical studies at the University of Tübingen, followed by postdoctoral training in reproductive immunology at McMaster University and the University of Toronto in Canada. She then pursued a residency at the University Women’s Hospital in Würzburg and held a senior research position at Charité, University Medicine Berlin, where she also served as a faculty member in Psycho-Neuro-Immunology. In 2006, she was awarded a Canada Research Chair and became a Full Professor of Neuroimmunology at McMaster University. She returned to Germany in 2010 to assume her current role at UKE.
Since 2018, Dr. Arck has served as the Dean of Research for the Medical Faculty at UKE. Her dedication to advancing feto-maternal medicine is further exemplified by her role as a board member of the Hamburg Center for Translational Immunology (HCTI).
Prof. Dr. Manuel A. Friese
HCTI Board Member
Prof. Dr. Manuel A. Friese is a distinguished neurologist and neuroimmunologist at the University Medical Center Hamburg-Eppendorf (UKE). He serves as the Director of the Institute of Neuroimmunology and Multiple Sclerosis (INIMS) at the Center for Molecular Neurobiology Hamburg (ZMNH), where his research focuses on the development and progression of neuroimmunological and neuroinfectious diseases, with a particular emphasis on multiple sclerosis.
Prof. Friese studied medicine at the Universities of Hamburg, Oxford, and University College London, obtaining his MD in 2001. He completed his neurology training at the Universities of Tübingen and Hamburg. Following a postdoctoral fellowship at the University of Oxford from 2004 to 2008, he established his laboratory as an Emmy Noether research fellow of the Deutsche Forschungsgemeinschaft at the University of Hamburg.
Since 2013, Prof. Friese has been a consultant neurologist and Professor of Neuroimmunology at the University of Hamburg, and since 2014, he has directed the INIMS. His laboratory aims to translate molecular findings into improved treatments and clinical care for patients with neuroimmunological conditions.
As a board member of the Hamburg Center for Translational Immunology (HCTI), Prof. Friese contributes his expertise in neuroimmunology to advance translational research and improve treatments for neuroimmune diseases.
Prof. Dr. Samuel Huber
HCTI Board Member
Prof. Dr. Samuel Huber is a renowned gastroenterologist and immunologist at the University Medical Center Hamburg-Eppendorf (UKE). He currently serves as the Director of the I. Department of Medicine (Gastroenterology). His research focuses on intestinal immune regulation, particularly the interplay between microbiota, tissue, and immune cells, to pave the way for future therapies for chronic inflammatory diseases and cancer.
Prof. Dr. Huber completed his medical studies at the Universities of Ulm, Heidelberg, and Mainz between 1999 and 2006. He earned his MD with summa cum laude honors from the University of Mainz in 2006. Following his medical residency in Internal Medicine at UKE, he pursued a postdoctoral fellowship in the Department of Immunobiology at Yale University from 2008 to 2012. Upon returning to UKE, he held various positions, including Head of the Section of Molecular Immunology and Gastroenterology and Senior Physician overseeing the outpatient unit for Inflammatory Bowel Disease. In 2018, he was appointed as an Endowed W3 Heisenberg-Professor for Intestinal Immune Regulation, and in 2019, he assumed his current role as Director of the I. Department of Medicine together with Prof. Dr. Ansgar W. Lohse.
As a board member of the Hamburg Center for Translational Immunology (HCTI), Prof. Dr. Huber plays a key role in bridging fundamental immunology with clinical gastroenterology to develop innovative therapies for immune-mediated diseases.
Prof. Dr. Ulf Panzer
HCTI Board Member
Prof. Dr. Ulf Panzer is a leading expert in translational immunology at the University Medical Center Hamburg-Eppendorf (UKE). He holds a W3 Professorship at the III. Department of Medicine and serves as the Director of the Hamburg Center for Translational Immunology (HCTI). His research mission focuses on improving the understanding of tissue-specific immunity in the kidney, aiming to translate these insights into better patient care.
Prof. Panzer studied medicine at the University of Hamburg from 1989 to 1996 and subsequently pursued studies in Molecular Biology at the Center for Molecular Neurobiology Hamburg (ZMNH). He completed his MD thesis at UKE between 1993 and 1996. Following his assistant physician role at the III. Department of Medicine, he undertook a DFG Postdoctoral Fellowship at the Institute for Research in Biomedicine in Bellinzona, Switzerland, from 2003 to 2004. He returned to UKE as a consultant and, in 2010, was appointed as a W3 Professor and Chief of the Division of Glomerulonephritis Research/Translational Immunology. Starting over 10 years ago, he paved the way for the HCTI, further advancing research in inflammation, infection, and immunology.